logo

Morphosys Ag (MPSYY.PK)



Trade MPSYY.PK now with
  Date
  Headline
2/4/2020 4:04:01 PM MorphoSys Initiates Expanded Access Program In U.S. For Tafasitamab
1/13/2020 1:38:40 AM MorphoSys Enters Global Collaboration And Licensing Agreement With Incyte
12/30/2019 8:22:20 AM MorphoSys Announces Submission Of BLA For Tafasitamab In R/r DLBCL To FDA
11/6/2019 4:24:46 PM MorphoSys To Present Number Of Important Updates On Tafasitamab At ASH
10/29/2019 5:14:25 PM MorphoSys Re-affirms FY19 Guidance
10/29/2019 3:58:41 PM MorphoSys Says Primary Endpoint Of Re-MIND Has Been Met
10/28/2019 4:55:17 PM MorphoSys: MOR106 Clinical Development In Atopic Dermatitis Ended For Futility
10/14/2019 7:22:22 AM MorphoSys And I-Mab Biopharma Announce IND Clearance To Begin Clinical Trials Of MOR202/TJ202
9/16/2019 8:18:27 AM MorphoSys's Licensee Janssen Submits Biologics License Application Of Tremfya
8/6/2019 4:19:25 PM MorphoSys Q2 Loss Per Share EUR 0.19 Vs Loss EUR 0.76 Last Year
8/6/2019 4:05:49 PM MorphoSys Report Specifications Of Biomarker Implemented In Phase 3 B-MIND Study
  
 
>